Effectiveness of Tobacco Cessation Interventions in Sweden
RSP
3 other identifiers
observational
8,000
1 country
8
Brief Summary
Smoking is still one of the most important risk factors causing morbidity and mortality in Sweden. Every year, 12,000 Swedish citizens die prematurely from smoking, and smoking is responsible for up to 60% of the inequity in health. Though the smoking prevalence is relatively low in Sweden in an international context (8% and 10% for men and women respectively in 2016), specific vulnarable groups have a very high prevalence; e.g. about 80% in alcohol and drug abusers. Furthermore, Sweden has a unique high prevalence of snus users and in 2016 the daily use of tobacco was 25% for men and 14% for women. In addition, products such as cigarettes, snus, and e-cigettes are often mixed. Despite the fact that about a thousand counsellors have been trained in manual-based person-centred tobacco cessation interventions in Sweden, the effectiveness of the interventions remains unknown, as a follow-up on effect of in-person interventions is not systematically collected in Sweden. Therefore, as of today it is not possible, on a national level, to compare the effectiveness of differences in these interventions, providers, or different groups of tobacco users including disadvantaged and vulnerable groups. In this study the investigators will evaluate the effectiveness of already implemented in-person cessation interventions targeting smoking, use of snus and/or e-cigarettes, focusing on disadvantaged and vulnerable groups of tobacco users. Furthermore, important factors associated with a successful outcome after controlling for confounders will be identified (in relation to programme, patients and setting).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2020
CompletedFirst Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedAugust 18, 2022
August 1, 2022
2.6 years
March 23, 2021
August 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
% of patients that are continuously smokefree
Self-reported smoking status, questionnaire completed by telephone interview
6 months
Secondary Outcomes (3)
% of patients that are smokefree
On completion of the tobacco cessation programme (app. 1 month after quitting)
% of patients that have been smokefree for at least the latest 14 days
6 months
% of patients that are satisfied with the smoking cessation intervention
6 months
Study Arms (2)
Exposed
Several studies will be performed based on this cohort. I each study the exposed group will be a group of tobacco users evaluatedin the relevant study. This could be a vulnarable group tobacco users such as: users without a job, with short or no education, without permanent housing, diagnosed with mental illness, diagnosed with chronic obstructive pulmonary disease (COPD), undergoing surgery, adolescents, elderly, migrants, or pregnant women.
Unexposed
In each study the unexposed group will consist of tobacco user from the study cohort without the condition examined in the relevant study.
Interventions
Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden
Eligibility Criteria
The population in this study are tobacco users in Sweden, who have attented an in-person tobacco cessation programme.
You may qualify if:
- Both individual and group-based interventions can be included.
You may not qualify if:
- Withdrawing consent.
- Reduced ability to give informed consent, due to inadequate language skills, dementia, and other conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
Study Sites (8)
Tobaksavvänjningen, Kirurgisk mott., CLV Växjö lasarett
Vaxjo, Kronoberg County, Sweden
Capio Go
Malmo, Skåne County, Sweden
Livsstilsmedicin Österåsen
Sollefteå, Västernorrland County, Sweden
Tobakspreventiva enheten, USÖ
Örebro, Sweden
Tybble vårdcentral
Örebro, Sweden
Ekeby Hälsocenter
Uppsala, Sweden
Flogsta vårdcentral
Uppsala, Sweden
Tobakspreventiv mottagning Karlskoga
Karlskoga, Örebro County, Sweden
Related Publications (1)
Rasmussen M, Larsson M, Gilljam H, Adami J, Warjerstam S, Post A, Bjork-Eriksson T, Helgason AR, Tonnesen H. Effectiveness of tobacco cessation interventions for different groups of tobacco users in Sweden: a study protocol for a national prospective cohort study. BMJ Open. 2022 Jan 25;12(1):e053090. doi: 10.1136/bmjopen-2021-053090.
PMID: 35078840BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hanne Tønnesen, DSc
Lund University, Clinical health promotion centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 23, 2021
First Posted
March 26, 2021
Study Start
April 9, 2020
Primary Completion
December 1, 2022
Study Completion
December 1, 2023
Last Updated
August 18, 2022
Record last verified: 2022-08